Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00447525 | REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children | PHASE3 | COMPLETED | 760 | — | — | Feb 1, 2007 | Jan 1, 2008 | Sep 11, 2017 | 64 | France |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | - |
| 2 | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| REVAXIS® | BIOLOGICAL | - |
| DT-Polio® | BIOLOGICAL | - |
Inclusion Criteria: 1. Healthy child without chronic severe disease of either gender, 2. 6 year-old child on vaccination day, 3. Child previously vaccinated with three doses of a diphtheria, tetanus and poliomyelitis containing vaccine given alone or in combination within the first 6 months of life...